Previous 10 | Next 10 |
The Hottest Penny Stock Trends And How to Use Them to Your Advantage Penny stocks are the talk of the town and for good reason. Throughout 2020 and 2021, investors have been searching high and low to find the best penny stocks to watch . And while some traders are more experienced t...
InspireMD (NSPR) announces a 1-for-15 reverse split of its common stock, effective as of Apr. 26, 2021.That means the company's outstanding shares will be reduced from approximately 118M to ~7.9M. The stock will trade on split adjusted basis from the market open on Apr. 27, 2021.Press Re...
TEL AVIV, Israel, April 14, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR, NSPR.WS, NSPR.WSB), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced a 1-for-15 rev...
Are These Hot Penny Stocks To Buy Right Now? There is a lot of excitement involving penny stocks this year. Much of this has stemmed from the pandemic, sure, but there are other things to factor in more recently. In recent weeks, one of the more active market sectors has been biotech, a...
TEL AVIV, Israel, March 22, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of the stroke caused by carotid artery disease, today issues a message to stockholders from InspireMD CEO, Marvin Sl...
Do These Biotech Penny Stocks Have Market Potential Right Now? Recently biotech penny stocks have been performing well in the market. The ongoing pandemic brought a lot of new attention to these stocks. Plenty of corporations started working on creating COVID-related vaccines or treatme...
Will These 4 Penny Stocks Keep Up Their Bullishness This Week? Penny stocks have been on a bullish journey this month. While there have been days where the market is down, investors are showing a lot of upbeat sentiment toward the future. In March, the path of Covid has changed dramatic...
InspireMD, Inc. (NSPR) Q4 2020 Earnings Conference Call March 09, 2021, 08:30 AM ET Company Participants Scott Gordon - President, Core IR, Investor Relations Marvin Slosman - Chief Executive Officer Craig Shore - Chief Financial Officer Conference Call Participants Benjamin Haynor - Alliance...
InspireMD (NSPR): Q4 GAAP EPS of -$0.10 misses by $0.03.Revenue of $0.16M (-84.2% Y/Y) misses by $0.94M.Press Release For further details see: InspireMD EPS misses by $0.03, misses on revenue
TEL AVIV, Israel, March 09, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced financial and operating results f...
News, Short Squeeze, Breakout and More Instantly...
-Conference call and webcast to be held at 8:30 a.m. EDT- TEL AVIV, Israel, and MIAMI, July 30, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease and stroke prev...
Series H warrants exercisable following release of positive outcomes results related to one-year follow-up from the Company’s C-GUARDIANS pivotal trial. Participating warrant holders include Marshall Wace, OrbiMed, Rosalind, Nantahala, Soleus, Velan, and certain InspireMD Board m...
Data demonstrate lowest reported primary endpoint event rate of 1.95% through twelve months post-procedure for any carotid stent or embolic protection device pivotal trial Study results to support a Premarket Approval (PMA) application to FDA in H2 2024 U.S. commercial launch of...